Brief: - FDA Grants Clearance For Getinge's Vasoview Hemopro 3
March 8 (Reuters) - Getinge AB GETIb.ST :
* FDA HAS GRANTED 510(K) CLEARANCE FOR VASOVIEW HEMOPRO 3
* IS PREPARING TO LAUNCH VASOVIEW HEMOPRO 3 IN US IN Q3
Source text for Eikon: ID:nWkr66vDDS
Further company coverage: GETIb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Getinge publ AB
See all newsBrief: CEO Buys SEK 4.7 Million Of Getinge Shares
Johnson & Johnson defeats heart-pump patent claims in US trial (updated)
Johnson & Johnson defeats heart-pump patent claims in US trial
Brief: Getinge's Subsidiary Maquet Cardiovascular Receives Adverse Jury Trial Verdict In Patent Infringement Dispute With Abiomed In U.S.
Getinge lags profit estimates as uncertainty curbs investments in medical equipment